ABSI
Price
$2.73
Change
-$0.10 (-3.53%)
Updated
Jul 10 closing price
Capitalization
360.99M
39 days until earnings call
BSEM
Price
$12.45
Change
+$0.20 (+1.63%)
Updated
Jul 10 closing price
Capitalization
204.49M
46 days until earnings call
Interact to see
Advertisement

ABSI vs BSEM

Header iconABSI vs BSEM Comparison
Open Charts ABSI vs BSEMBanner chart's image
Absci
Price$2.73
Change-$0.10 (-3.53%)
Volume$2.96M
Capitalization360.99M
BioStem Technologies
Price$12.45
Change+$0.20 (+1.63%)
Volume$41.38K
Capitalization204.49M
ABSI vs BSEM Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. BSEM commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and BSEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ABSI: $2.73 vs. BSEM: $12.45)
Brand notoriety: ABSI and BSEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 86% vs. BSEM: 78%
Market capitalization -- ABSI: $360.99M vs. BSEM: $204.49M
ABSI [@Biotechnology] is valued at $360.99M. BSEM’s [@Biotechnology] market capitalization is $204.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileBSEM’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • BSEM’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than BSEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 3 TA indicator(s) are bullish while BSEM’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 3 bullish, 6 bearish.
  • BSEM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both ABSI and BSEM are a bad buy in the short-term.

Price Growth

ABSI (@Biotechnology) experienced а -1.44% price change this week, while BSEM (@Biotechnology) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 05, 2025.

BSEM is expected to report earnings on Aug 26, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($361M) has a higher market cap than BSEM($204M). ABSI YTD gains are higher at: 4.198 vs. BSEM (-10.043). BSEM has higher annual earnings (EBITDA): -8.62M vs. ABSI (-93.91M). ABSI has more cash in the bank: 134M vs. BSEM (110K). BSEM has less debt than ABSI: BSEM (6.02M) vs ABSI (8.92M). BSEM has higher revenues than ABSI: BSEM (6.04M) vs ABSI (4.82M).
ABSIBSEMABSI / BSEM
Capitalization361M204M177%
EBITDA-93.91M-8.62M1,090%
Gain YTD4.198-10.043-42%
P/E RatioN/A8.47-
Revenue4.82M6.04M80%
Total Cash134M110K121,818%
Total Debt8.92M6.02M148%
FUNDAMENTALS RATINGS
BSEM: Fundamental Ratings
BSEM
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIBSEM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLNSF10.450.21
+2.05%
Velan Inc.
BJTRF0.65N/A
N/A
Beijing Tong Ren Tang Chinese Medicine Co Ltd, Hong Kong
TGLDF0.09N/A
N/A
RENEGADE GOLD INC.
UMICY4.09-0.09
-2.04%
Umicore SA
TOELF187.83-4.47
-2.32%
Tokyo Electron Ltd.

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-3.53%
RXRX - ABSI
64%
Loosely correlated
+2.24%
CRSP - ABSI
61%
Loosely correlated
-1.80%
BEAM - ABSI
58%
Loosely correlated
+2.66%
ABCL - ABSI
56%
Loosely correlated
+9.25%
NTLA - ABSI
49%
Loosely correlated
+0.25%
More

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VTYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
+1.63%
VTYX - BSEM
22%
Poorly correlated
+18.33%
ABSI - BSEM
20%
Poorly correlated
-3.53%
AURA - BSEM
20%
Poorly correlated
+2.73%
CELU - BSEM
20%
Poorly correlated
+1.89%
CLVLY - BSEM
11%
Poorly correlated
-6.14%
More